(Q40662735)

22 September 2017

title

Overexpression of hepatocyte growth factor receptor in renal carcinoma cells indirectly stimulates tumor growth in vivo (English)

1 reference

22 September 2017

1 reference

1 reference

Yasuyoshi Miyata

1

1 reference

22 September 2017

Shingo Ashida

2

1 reference

22 September 2017

Takao Nakamura

3

1 reference

22 September 2017

Yasushi Mochizuki

4

1 reference

22 September 2017

Shigehiko Koga

5

1 reference

22 September 2017

Hiroshi Kanetake

6

1 reference

22 September 2017

Taro Shuin

7

1 reference

22 September 2017

Shigeru Kanda

8

1 reference

22 September 2017

publication date

1 March 2003

1 reference

Biochemical and Biophysical Research Communications

22 September 2017

published in

1 reference

22 September 2017

volume

302

1 reference

22 September 2017

issue

4

1 reference

22 September 2017

page(s)

892-897

1 reference

Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900281-X

The HGF receptor family: unconventional signal transducers for invasive cell growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900281-X

Met receptor tyrosine kinase: enhanced signaling through adapter proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900281-X

Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900281-X

Novel mutations of the MET proto-oncogene in papillary renal carcinomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900281-X

A novel germ line juxtamembrane Met mutation in human gastric cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900281-X

Activating mutations for the met tyrosine kinase receptor in human cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900281-X

Frequent amplification of the c-met gene in scirrhous type stomach cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900281-X

Overexpression of the Met/HGF receptor in ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900281-X

Non-autocrine, constitutive activation of Met in human anaplastic thyroid carcinoma cells in culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900281-X

MET receptor is overexpressed but not mutated in oral squamous cell carcinomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900281-X

Increase in hepatocyte growth factor receptor tyrosine kinase activity in renal carcinoma cells is associated with increased motility partly through phosphoinositide 3-kinase activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900281-X

Cyclooxygenase regulates angiogenesis induced by colon cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900281-X

Maspin is an angiogenesis inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900281-X

HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900281-X

Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900281-X

PTEN/MMAC1/TEP1 in signal transduction and tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900281-X

PTEN/MMAC1/TEP1 mutations in human primary renal-cell carcinomas and renal carcinoma cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900281-X

Angiogenesis in cancer and other diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900281-X

HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900281-X

Normoxic induction of the hypoxia-inducible factor 1alpha by insulin and interleukin-1beta involves the phosphatidylinositol 3-kinase pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900281-X

Constitutive activation of c-Jun N-terminal kinase by a mutant epidermal growth factor receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900281-X

Different pathways of postreceptor desensitization following chronic insulin treatment and in cells overexpressing constitutively active insulin receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900281-X

Constitutive activation of phosphatidylinositol 3-kinase by a naturally occurring mutant epidermal growth factor receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2803%2900281-X

10.1016/S0006-291X(03)00281-X

7 January 2021

Identifiers

DOI

1 reference

22 September 2017

1 reference